Agenus, Inc. (AGEN)
6.86
-0.03
(-0.44%)
USD |
NASDAQ |
Sep 11, 12:56
Agenus Gross Profit (TTM) : 127.32M for June 30, 2026
Gross Profit (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 127.32M |
| March 31, 2026 | 115.60M |
| December 31, 2025 | 103.18M |
| September 30, 2025 | 93.03M |
| June 30, 2025 | 88.08M |
| March 31, 2025 | 85.84M |
| December 31, 2024 | 89.63M |
| September 30, 2024 | 144.52M |
| June 30, 2024 | 144.05M |
| March 31, 2024 | 146.09M |
| December 31, 2023 | 139.61M |
| September 30, 2023 | 80.08M |
| June 30, 2023 | 79.68M |
| March 31, 2023 | 74.82M |
| December 31, 2022 | 80.51M |
| September 30, 2022 | 79.43M |
| June 30, 2022 | 309.13M |
| March 31, 2022 | 300.26M |
| December 31, 2021 | 285.41M |
| September 30, 2021 | 296.30M |
| June 30, 2021 | 57.92M |
| March 31, 2021 | 74.10M |
| December 31, 2020 | 65.21M |
| September 30, 2020 | 36.59M |
| June 30, 2020 | 24.52M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 6.910M |
| June 30, 2018 | 6.910M |
| March 31, 2018 | 6.910M |
| December 31, 2017 | 6.910M |
| September 30, 2017 | 4.287M |
| June 30, 2017 | 7.594M |
| March 31, 2017 | 7.594M |
| December 31, 2016 | 7.594M |
| September 30, 2016 | 3.308M |
| June 30, 2016 | 6.330M |
| March 31, 2016 | 12.27M |
| December 31, 2015 | 12.27M |
| September 30, 2015 | 13.32M |
| June 30, 2015 | 8.124M |
| March 31, 2015 | 4.939M |
| December 31, 2014 | 5.393M |
| September 30, 2014 | 4.587M |
| June 30, 2014 | 3.973M |
| March 31, 2014 | 1.853M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| Novavax, Inc. | 325.46M |
| Amgen, Inc. | 27.78B |
| Anika Therapeutics, Inc. | 75.00M |
| BioCryst Pharmaceuticals, Inc. | 917.38M |
| Imunon, Inc. | -0.6718M |